Chemokine/ITGA4 Interaction Directs iPSC-Derived Myogenic Progenitor Migration to Injury Sites in Aging Muscle for

Muhammad Ashraf1, Srinivas M Tipparaju1, Joung Woul Kim1

  • 1Department of Pharmaceutical Sciences, USF Health Taneja College of Pharmacy, University of South Florida, Tampa, FL 33612, USA.

Cells
|July 29, 2023
PubMed

Insights

Muscle progenitor cells (MPCs) use ITGA4 to sense injury signals and migrate to repair aged muscle. This finding is crucial for understanding and treating age-related muscle mass loss.

Area of Science:

  • Regenerative Medicine
  • Cell Biology
  • Aging Research

Background:

  • Muscle mass loss during aging is linked to impaired muscle repair after injury.
  • Muscle progenitor cells (MPCs) are essential for muscle regeneration.
  • Human-induced pluripotent stem-cell-derived MPCs (Givi-MPCs) offer a potential therapeutic source.

Purpose of the Study:

  • To investigate the role of integrin alpha 4 (ITGA4) in directing Givi-MPC migration to sites of muscle injury.
  • To determine if chemokines from injured endothelial cells, via ITGA4, guide MPCs to the injury site.

Main Methods:

  • Generated Givi-MPCs from human iPSCs.
  • Knocked down ITGA4 expression in Givi-MPCs using shRNA lentiviral vectors.
  • Assessed cell migration in vitro (wound-healing, transwell assays) and cell mobilization in vivo using aged mouse models (NSG, mdx/scid).

Main Results:

  • ITGA4 was highly expressed in Givi-MPCs.
  • Knockdown of ITGA4 significantly impaired Givi-MPC migration in vitro and in vivo.
  • Impaired migration was observed towards TNF-α-treated human aortic endothelial cells (HAECs) expressing CX3CL1 and VCAM-1.

Conclusions:

  • MPCs expressing ITGA4 utilize chemokines from injured endothelial cells as chemoattractant signals for migration to injured muscle.
  • Ligand-receptor interactions involving ITGA4 mediate Givi-MPC mobilization and subsequent engraftment for sarcopenic muscle repair.